Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
The Queen has sent her first ever tweet - personally pressing send on a tablet at the Science Museum on London.
Aaron Paul has joined a campaign calling on Toys R Us to return Breaking Bad action figures to shelves.
Welsh-born actor Christian Bale will play the role of Steve Jobs in an upcoming Hollywood film about the life of the Apple co-founder.